Literature DB >> 2598036

Correlative decrease of large neurons in the neostriatum and basal nucleus of Meynert in Alzheimer's disease.

K Oyanagi1, H Takahashi, K Wakabayashi, F Ikuta.   

Abstract

A quantitative investigation was performed on the large neurons in the neostriatum and basal nucleus of Meynert (bnM) in patients with Alzheimer's disease (AD) and progressive supranuclear palsy (PSP). The degree of decrease of the large neurons in the neostriatum was quite similar to that in the bnM; these decreases were significantly correlative in AD, but not in PSP. These findings indicate that the large neurons in the neostriatum and bnM, which are considered to be cholinergic and to exclusively possess nerve growth factor receptors in the cerebrum, degenerate simultaneously in an equal ratio in AD.

Entities:  

Mesh:

Year:  1989        PMID: 2598036     DOI: 10.1016/0006-8993(89)91384-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  D1-like dopamine receptors selectively block P/Q-type calcium channels to reduce glutamate release onto cholinergic basal forebrain neurones of immature rats.

Authors:  Toshihiko Momiyama; Yugo Fukazawa
Journal:  J Physiol       Date:  2007-01-18       Impact factor: 5.182

2.  Modulation of inhibitory transmission by dopamine in rat basal forebrain nuclei: activation of presynaptic D1-like dopaminergic receptors.

Authors:  T Momiyama; J A Sim
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

Review 3.  Neuropathology of parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam: an update.

Authors:  K Oyanagi; M Wada
Journal:  J Neurol       Date:  1999-09       Impact factor: 4.849

4.  Regulation of the intracellular free calcium concentration in acutely dissociated neurones from rat nucleus basalis.

Authors:  H Tatsumi; Y Katayama
Journal:  J Physiol       Date:  1993-05       Impact factor: 5.182

5.  Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation.

Authors:  G M Halliday; H L McCann; R Pamphlett; W S Brooks; H Creasey; E McCusker; R G Cotton; G A Broe; C G Harper
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

6.  Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse.

Authors:  Sylvia E Perez; Saleem Dar; Milos D Ikonomovic; Steven T DeKosky; Elliott J Mufson
Journal:  Neurobiol Dis       Date:  2007-06-27       Impact factor: 5.996

7.  The neostriatum and nucleus accumbens in parkinsonism-dementia complex of Guam: a pathological comparison with Alzheimer's disease and progressive supranuclear palsy.

Authors:  K Oyanagi; T Makifuchi; T Ohtoh; K M Chen; D C Gajdusek; T N Chase; F Ikuta
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 8.  Sequence-specific effects of neurokinin substance P on memory, reinforcement, and brain dopamine activity.

Authors:  J P Huston; R U Hasenöhrl; F Boix; P Gerhardt; R K Schwarting
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 9.  Dopamine and Serotonin-Induced Modulation of GABAergic and Glutamatergic Transmission in the Striatum and Basal Forebrain.

Authors:  Toshihiko Momiyama; Takuma Nishijo
Journal:  Front Neuroanat       Date:  2017-05-11       Impact factor: 3.856

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.